Touchlight unveils next-gen circular DNA portfolio for advanced gene therapies
The expanded mbDNA portfolio delivers enhanced stability, reduced immunogenicity, and broad compatibility with gene insertion and expression technologies
The expanded mbDNA portfolio delivers enhanced stability, reduced immunogenicity, and broad compatibility with gene insertion and expression technologies
The company has introduced an innovative Dual Release Proton Pump Inhibitor (PPI) tablet, a next-generation therapy for patients suffering from moderate to severe or treatment resistant gastroesophageal reflux disease
PET sheets are widely recognised for their superior clarity, strength, and barrier properties
Expanding US operations to address the increased demand for API development and manufacturing
Lutavit A/D3 1000/200 NXT provides a combination of vitamin A and vitamin D3 in one formulation
PeptiGlow features premium-grade hydrolyzed collagen peptides that support skin elasticity and hydration
Pfizer will participate in TrumpRx.gov, a direct-to-patient purchasing platform offering discount up to 85%
Ultra-high purity surfactant for biologics and parenteral drug formulations
First fully automated, cartridge-based companion diagnostic test for colorectal cancer patients approved in the United States
Nu Nutridac is a nutritional replenisher for neurodegenerative and anxiety-related disorders
Subscribe To Our Newsletter & Stay Updated